Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Psychiatry/Psychology | Neurology | Family Medicine
 Disease Category: Depression (Major/Severe)
Location: United States, IL

Trial Information

A multicenter, randomized, double-blind, parallel group, placebo controlled, phase III, efficacy and safety study of 3 fixed dose groups of TC-5214 (S-mecamylamine) as an adjunct to an antidepressant in patients with Major Depressive Disorder who exhibit an inadequate resopnse to antidepressant therapy.

To evaluate if a compound called TC-5214 works better than placebo when added to current antidepressant therapy in patients who are experiencing an inadequate response to current therapy.

Please contact Alexian Brothers for more information on participation.

Alexian Brothers Hospital Network
1786 Moon Lake Blvd, Suite 200
Hoffman Estates, IL 60169
Phone: 847-230-3599
Email: philip.carona@alexian.net

View Map

Research Center Information: Alexian Brothers Hospital Network

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:  
Message:
 

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.